Ignite Creation Date:
2024-05-05 @ 5:11 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00402532
Status:
COMPLETED
Last Update Posted:
2011-12-08
First Post:
2006-11-20
Brief Title:
Immunosuppressive Therapy With Certican Everolimus After Lung Transplantation
Sponsor:
Hannover Medical School
Organization:
Hannover Medical School
Organization Data
Organization:
Hannover Medical School
Class:
OTHER
Study ID:
Ever-Lung-DE01RAD-LungDE01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Hannover Medical School
Lead Sponsor Class:
OTHER
Responsible Party:
Martin Strueber
Responsible Party Title:
Martin Strueber MD
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Hannover Medical School
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Novartis Pharmaceuticals | INDUSTRY |